VISTAGEN THERAPEUTICS INC's ticker is VTGN and the CUSIP is 92840H202. A total of 26 filers reported holding VISTAGEN THERAPEUTICS INC in Q1 2019. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2022 | $25,000 | -35.9% | 20,000 | 0.0% | 0.02% | -31.4% |
| Q4 2021 | $39,000 | -29.1% | 20,000 | 0.0% | 0.04% | -37.5% |
| Q3 2021 | $55,000 | -12.7% | 20,000 | 0.0% | 0.06% | -13.8% |
| Q2 2021 | $63,000 | +46.5% | 20,000 | 0.0% | 0.06% | +35.4% |
| Q1 2021 | $43,000 | +10.3% | 20,000 | 0.0% | 0.05% | 0.0% |
| Q4 2020 | $39,000 | +178.6% | 20,000 | 0.0% | 0.05% | +140.0% |
| Q3 2020 | $14,000 | +27.3% | 20,000 | 0.0% | 0.02% | +25.0% |
| Q2 2020 | $11,000 | +22.2% | 20,000 | 0.0% | 0.02% | +6.7% |
| Q1 2020 | $9,000 | -35.7% | 20,000 | 0.0% | 0.02% | -16.7% |
| Q4 2019 | $14,000 | -33.3% | 20,000 | 0.0% | 0.02% | -37.9% |
| Q3 2019 | $21,000 | +40.0% | 20,000 | 0.0% | 0.03% | +61.1% |
| Q2 2019 | $15,000 | -42.3% | 20,000 | 0.0% | 0.02% | -18.2% |
| Q1 2019 | $26,000 | -13.3% | 20,000 | 0.0% | 0.02% | -18.5% |
| Q4 2018 | $30,000 | +3.4% | 20,000 | 0.0% | 0.03% | +17.4% |
| Q3 2018 | $29,000 | +7.4% | 20,000 | 0.0% | 0.02% | +4.5% |
| Q2 2018 | $27,000 | – | 20,000 | – | 0.02% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| ACUTA CAPITAL PARTNERS, LLC | 11,728,033 | $32,135,000 | 11.34% |
| VR Adviser, LLC | 16,047,286 | $43,970,000 | 5.65% |
| COMMODORE CAPITAL LP | 5,123,509 | $14,038,000 | 3.70% |
| Ghost Tree Capital, LLC | 2,000,000 | $5,480,000 | 1.60% |
| EPIQ PARTNERS, LLC | 916,100 | $2,510,000 | 1.16% |
| SILVERARC CAPITAL MANAGEMENT, LLC | 707,733 | $1,939,000 | 1.10% |
| SPHERA FUNDS MANAGEMENT LTD. | 3,824,938 | $10,480,000 | 0.88% |
| HighVista Strategies LLC | 438,239 | $1,201,000 | 0.80% |
| Nicholas Investment Partners, LP | 2,786,354 | $7,635,000 | 0.56% |
| NEA Management Company, LLC | 16,302,596 | $44,669,000 | 0.53% |